Representative Works to Make Bone Marrow Donation Easier
After being a donor, one state law maker works to make it easier for others to donate:
"A state lawmaker wants to make it easier to saves lives.
State Rep. Mike Shelton was once able to give a 31-year-old woman suffering from Hodgkin's lymphoma the bone marrow she desperately needed to recover. Now, he plans to file legislation in the 2011 session to make it easier to others to do the same.
Shelton said his marrow donation to Patrice Tillman of Tucson, Ariz., opened his eyes to the need for more blood donors.
"Every year, thousands of patients are diagnosed with life-threatening diseases like leukemia and lymphoma, and a marrow transplant from someone who is not related to them is often their best hope for survival," Shelton, D-Oklahoma City, said. "Although there are more than 8 million volunteers on the national registry, about 20 percent of them are not available when their donation is needed because of work.""
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
